Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors

Summary

RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Phase I trial to study the effectiveness of monoclonal antibody therapy in treating patients who have relapsed or refractory solid tumors.

Timeline

Start

1999-12

Primary completion

2001-06

Completion

—

Drugs

Indications